Although much of the benefit of improvements in glycaemic control is in the prevention of long-term diabetes-related complications, glycaemic control is likely to affect some aspects of daily living, for example, the need for daily planning of injection times, dose adjustment or monitoring of glycaemic control (where indicated) for insulin-treated T2D [85]. This evidence concerns the gene INS and diabetes mellitus.